Cancer-associated VTE: A follow-up study collecting biological samples

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational cohort study aimed at understanding the recurrence risk and underlying mechanisms of venous thromboembolism in cancer patients. Researchers will collect blood samples at study entry and at recurrence events to build a biobank for future analyses, and urine samples annually for up to five years. The study follows patients with active cancer or those undergoing cancer treatment who recently experienced VTE, to better characterize risks, biology, and prognosis in this high-risk population. Interventions are limited to biological sample collection; no experimental therapies are used. The findings may help refine risk stratification and future research in cancer-associated VTE.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years and more.
* Patients with active cancer or requiring cancer treatment at the time of their VTE episode
* Patients with documented VTE less than 2 years old
* Patients affiliated to the social security system
* Patient who has signed a written informed consent

Exclusion Criteria:

* Patient under 18
* Refusal to participate
* Incapacity to consent to the study
* Patient under guardianship
* Incapacity to communicate (comprehension disorder)
* Life expectancy of less than 6 months

Where it's running

• Brest University Hospital
  Brest, France Recruiting

Study contacts

• Principal investigator: Françis Couturaud, Pr — CHU Brest
• Study coordinator: Françis Couturaud, Pr
• Email: francis.couturaud@chu-brest.fr
• Phone: +33298347348

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry of patients treated for venous thromboembolism

  This study is tracking patients with blood clots to see how different treatments work and to help with future research.

  Recruiting Medalp Private Surgery Clinic · Moscow, Moscow · NCT03881345

• Using apixaban to prevent strokes in patients with severe kidney disease and atrial fibrillation

  This study is testing if the blood thinner apixaban can help prevent strokes in people with severe kidney disease and atrial fibrillation.

  Recruiting at 29 sites Phase 3 Region Stockholm · Helsinki and 33 other locations · NCT05679024

• Unified care and integrated treatments for ADHD with substance use in prison settings

  Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.

  Recruiting University Hospital, Brest · Brest · NCT07487155

• 4D dynamic LAFOV FDG-PET to tell leftover cancer from post-radiation inflammation in head and neck squamous cell carcinoma

  This study will test whether a 4D dynamic long‑axial‑field‑of‑view FDG‑PET scan can tell remaining head and neck squamous cell cancer from normal post‑radiation inflammation in adults about three months after finishing curative radiotherapy.

  Recruiting University Hospital, Brest · Brest and 2 other locations · NCT07417605

• Imaging the anatomy of the eye socket (orbit)

  This project looks at existing orbital imaging from adults to see how the eye muscles, optic nerve, and orbital fat are arranged.

  Recruiting University Hospital, Brest · Brest · NCT07360470

• Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism

  This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.

  Recruiting University Hospital, Brest · Brest · NCT07328152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.